Abstract：Objective To explore the application of whole-genome sequencing (WGS) in the rapid clinical diagnosis of critically ill neonates. Methods The critically ill neonates who admitted to the neonatal intensive care unit of Children's Hospital of Fudan University and underwent WGS from August to September, 2019 were enrolled in this prospective study. The genetic testing results and clinical outcome were analyzed with reference to the sequencing data and clinical features of the neonates. Results A total of 15 neonates were tested, among whom there were 9 boys and 6 girls. The main reason for hospitalization included abnormal breathing in 7 neonates, poor response in 2 neonates, feeding difficulty in 2 neonates, fever in 1 neonate, hypothermia in 1 neonate, preterm birth in 1 neonate, and convulsion in 1 neonate. The mean turn-around time was 4.5 days for WGS. Finally a genetic diagnosis was obtained for 3 neonates, with a positive diagnostic rate of 20% (3/15). Among the 3 neonates, 2 neonates were withdrawn from the treatment due to severe conditions and 1 neonate died on the day when the sample was sent for genetic testing, whose etiology could be explained by the results of genetic testing. Conclusions WGS technique can provide a timely and effective diagnosis for critically ill neonates suspected of genetic diseases and provide genetic evidence for clinical treatment of critically ill cases.
XIAO Fei-Fan,LU Yu-Lan,WU Bing-Bing et al. Clinical practice of whole-genome sequencing in the rapid diagnosis of critically ill neonates[J]. CJCP, 2023, 25(2): 135-139.
Kingsmore SF, Cakici JA, Clark MM, et al. A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants[J]. Am J Hum Genet, 2019, 105(4): 719-733. PMID: 31564432. PMCID: PMC6817534. DOI: 10.1016/j.ajhg.2019.08.009.
de Castro MJ, González-Vioque E, Barbosa-Gouveia S, et al. Rapid phenotype-driven gene sequencing with the NeoSeq panel: a diagnostic tool for critically ill newborns with suspected genetic disease[J]. J Clin Med, 2020, 9(8): 2362. PMID: 32718099. PMCID: PMC7464859. DOI: 10.3390/jcm9082362.
Xiao F, Yan K, Tang M, et al. Diagnostic utility of rapid sequencing in critically ill infants: a systematic review and meta-analysis[J]. Expert Rev Mol Diagn, 2022, 22(8): 833-840. PMID: 36082848. DOI: 10.1080/14737159.2022.2123704.
Wang H, Lu Y, Dong X, et al. Optimized trio genome sequencing (OTGS) as a first-tier genetic test in critically ill infants: practice in China[J]. Hum Genet, 2020, 139(4): 473-482. PMID: 31965297. DOI: 10.1007/s00439-019-02103-8.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. PMID: 25741868. PMCID: PMC4544753. DOI: 10.1038/gim.2015.30.
Faienza MF, Giordani L, Ferraris M, et al. PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy: what is the link?[J]. Pediatr Cardiol, 2009, 30(7): 1012-1015. PMID: 19582499. DOI: 10.1007/s00246-009-9473-7.
Chen H, Li X, Liu X, et al. Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort[J]. Orphanet J Rare Dis, 2019, 14(1): 29. PMID: 30732632. PMCID: PMC6367752. DOI: 10.1186/s13023-019-1010-z.
Zhu T, Gong X, Bei F, et al. Application of next-generation sequencing for genetic diagnosis in neonatal intensive care units: results of a multicenter study in China[J]. Front Genet, 2020, 11: 565078. PMID: 33240318. PMCID: PMC7677510. DOI: 10.3389/fgene.2020.565078.
Dimmock DP, Clark MM, Gaughran M, et al. An RCT of rapid genomic sequencing among seriously ill infants results in high clinical utility, changes in management, and low perceived harm[J]. Am J Hum Genet, 2020, 107(5): 942-952. PMID: 33157007. PMCID: PMC7675004. DOI: 10.1016/j.ajhg.2020.10.003.
